Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-794-3 | CAS number: -
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
The following remarks on the toxicokinetics of the multi-constituent substance HPP 12879-1 (Reaction mass of 2,6-Bis[(dimethylamino)methyl]-4-(1-{3-[(dimethylamino)methyl]-4- hydroxyphenyl}-1-methylethyl)phenol and 4-(1-{3,5-Bis[(dimethylamino)methyl]-4-hydroxyphenyl}-1-methylethyl)-2,6 -bis[(dimethylamino)methyl]phenol) are based on physico-chemical properties of the compound and on available toxicological data. Experimental toxicokinetic studies were not performed.
The substance is a white organic solid with a very low vapour pressure under normal ambient conditions (2.1 x 10-4 Pa at 20°C), therefore inhalation exposure to the vapour is expected to be negligible.
The physico-chemical characteristics of the substance (good water solubility of 4.1 g/L at 20°C, moderate log Pow of 3.2 - 4.0 at 25°C and a molecular mass of 342 - 456 g/mol) are favourable for intestinal absorption after oral intake. Due to the lack of acute or subacute toxicity studies in animals there is no proof of systemic availability of the substance after oral administration.
Because of the moderate lipophilicity of HPP 12879-1 accumulation of the unchanged compound in fatty tissues would be conceivable in individuals that are frequently exposed to that substance.
Due to the good water solubility, a log Pow of 3.2 - 4.0 at 25°C and a molecular mass of 342 - 456 g/mol dermal absorption of the substance seems conceivable. However, no signs of systemic toxicity were observed in an acute dermal toxicity study in rats (LD50 > 2000 mg/kg bw; Haferkorn, 2016) and in a local lymph node assay (LLNA) in mice (Leidenfrost, 2016). As the skin sensitisation study revealed a moderate skin sensitising potential after dermal contact of the substance formulated in acetone/olive oil (4:1 v/v), at least for a solution of the substance in acetone/olive oil (4:1 v/v) some dermal absorption has to be assumed.
Based on the results of three in vitro genotoxicity tests (negative with and without metabolic activation in an Ames test (Sokolowski, 2015a), in a HPRT test (Wollny, 2016) as well as in a mammalian cell micronucleus test (Sokolowski, 2015b)) it is concluded that DNA-reactive metabolites of the substance will most probably not be generated in mammals in the course of hepatic biotransformation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
